At the Veeva MedTech Summit in Amsterdam, the discussion around artificial intelligence did not center on which tools could be adopted fastest. Instead, speakers and panelists returned repeatedly to a less glamorous question: whether MedTech organizations have the data, processes, governance and people needed to use AI reliably. The consensus was that digital transformation succeeds when those foundations are addressed first, not after adoption has begun.
That message was illustrated most clearly by Medtronic's four-year preparation for AI. Becki Brasher of Medtronic described work to harmonize processes, improve data consistency, consolidate systems and establish governance structures before implementation. Her formulation—'We didn't start with AI. We had to earn AI'—captures the logic. AI introduced into fragmented systems can produce outputs that are difficult to trust, validate or scale, creating more problems than it solves.
Foundations before algorithms
The Medtronic example shifts attention from model capability to organizational readiness. Reliable information and standardized processes are not peripheral IT concerns; they determine whether AI outputs can be reviewed, reproduced and extended across a business. The same applies to employees. Technology alone cannot deliver transformation, and staff need the knowledge, confidence and oversight to incorporate new tools into their responsibilities.
The account also suggests that preparation is not a one-time gate. Harmonizing data and consolidating systems creates the conditions for AI, but governance and training must continue as tools and uses expand.
Governance as a design input
Balancing innovation with regulatory compliance was another major theme, particularly in the closing keynote by Erik Orzechowski and Benjamin Rochette. They argued that MedTech organizations must move quickly without compromising quality, safety and regulatory standards. Their key proposal was to embed governance in technology development from the outset rather than treating it as a final compliance exercise.
That requires closer collaboration among IT, Quality and Regulatory teams. IT understands the technology and its implementation; Quality and Regulatory professionals assess risks and determine the evidence needed to demonstrate compliance. The speakers also called for proportionate governance. An AI application supporting relatively low-risk administrative work does not necessarily require the same controls as one influencing patient safety or regulatory decisions.
Clear responsibilities, early risk assessments and appropriate controls can therefore create a more flexible approach. In this framing, compliance and innovation are not opposing priorities: governance can provide the confidence needed to move forward.
Human judgment remains accountable
The summit also emphasized limits. Brasher made clear her view that AI should assist human reviewers rather than replace them. In an interview, she said human judgment will remain in place until organizations build trust that what agents deliver is accurate. AI can analyze large volumes of information, generate documentation and provide recommendations, but its outputs still require scrutiny. A convincing answer is not necessarily a correct one, especially in a highly regulated environment.
The closing keynote used an analogy: relying on AI without understanding its underlying subject matter is like using a calculator without knowing the mathematics behind it. The point is particularly relevant to the next generation of regulatory and quality professionals. If employees rely on AI before developing the necessary knowledge, organizations could end up with fewer people able to challenge inaccurate or inappropriate recommendations.
The consensus was not to avoid AI but to make it complement human expertise. AI can support research, analysis and documentation, while accountable individuals retain responsibility for important decisions.
From pilots to scalable value
Another consideration was whether AI investments deliver genuine business value. With many potential applications available, organizations need to resist pursuing every opportunity at once. Instead, they should identify areas where technology addresses existing operational challenges and define clear measures of success.
The closing keynote highlighted several value measures, including time savings, reduced process cycle times, less rework, improved quality and employee adoption. Controlled pilot projects can show where AI is most effective, preserve human oversight and build confidence before successful applications are expanded.
Because the technology landscape will continue to evolve, governance structures must be able to adapt alongside new capabilities and changing regulatory expectations. Success will depend less on the number of AI initiatives launched than on the ability to turn promising applications into reliable, scalable business capabilities.
The summit's broader message was that digital transformation is a collective challenge. Technology, regulatory compliance, data management and organizational culture cannot be addressed independently. Progress will require closer collaboration within companies and continued engagement among manufacturers, technology providers, regulators and other stakeholders.
The tone was optimistic but pragmatic. AI offers significant opportunities for medical technology, yet realizing them requires patience, preparation and a clear understanding of where human expertise remains indispensable. Orzechowski's phrase 'slow down to speed up' summarizes the approach: getting the foundations right today is presented as the basis for embracing tomorrow's technological opportunities.
